These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 36053514)
1. Long-Term MC4R Agonist Treatment in POMC-Deficient Patients. Kühnen P; Clément K N Engl J Med; 2022 Sep; 387(9):852-854. PubMed ID: 36053514 [No Abstract] [Full Text] [Related]
2. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. Clément K; van den Akker E; Argente J; Bahm A; Chung WK; Connors H; De Waele K; Farooqi IS; Gonneau-Lejeune J; Gordon G; Kohlsdorf K; Poitou C; Puder L; Swain J; Stewart M; Yuan G; Wabitsch M; Kühnen P; Lancet Diabetes Endocrinol; 2020 Dec; 8(12):960-970. PubMed ID: 33137293 [TBL] [Abstract][Full Text] [Related]
4. Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment. Ayers KL; Glicksberg BS; Garfield AS; Longerich S; White JA; Yang P; Du L; Chittenden TW; Gulcher JR; Roy S; Fiedorek F; Gottesdiener K; Cohen S; North KE; Schadt EE; Li SD; Chen R; Van der Ploeg LHT J Clin Endocrinol Metab; 2018 Jul; 103(7):2601-2612. PubMed ID: 29726959 [TBL] [Abstract][Full Text] [Related]
5. Pro-opiomelanocortin (POMC) deficiency and peripheral melanocortins in obesity. Zemel MB; Shi H Nutr Rev; 2000 Jun; 58(6):177-80. PubMed ID: 10885325 [TBL] [Abstract][Full Text] [Related]
6. Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist. Kühnen P; Clément K; Wiegand S; Blankenstein O; Gottesdiener K; Martini LL; Mai K; Blume-Peytavi U; Grüters A; Krude H N Engl J Med; 2016 Jul; 375(3):240-6. PubMed ID: 27468060 [TBL] [Abstract][Full Text] [Related]
7. Differential control of metabolic and cardiovascular functions by melanocortin-4 receptors in proopiomelanocortin neurons. do Carmo JM; da Silva AA; Rushing JS; Pace B; Hall JE Am J Physiol Regul Integr Comp Physiol; 2013 Aug; 305(4):R359-68. PubMed ID: 23842677 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic neuronal melanocortin-4 receptor modulates serum insulin levels independent of leptin receptor. Mansour M; White D; Wernette C; Dennis J; Tao YX; Collins R; Parker L; Morrison E Endocrine; 2010 Feb; 37(1):220-30. PubMed ID: 20963574 [TBL] [Abstract][Full Text] [Related]
9. Pro-opiomelanocortin processing in the hypothalamus: impact on melanocortin signalling and obesity. Pritchard LE; Turnbull AV; White A J Endocrinol; 2002 Mar; 172(3):411-21. PubMed ID: 11874690 [TBL] [Abstract][Full Text] [Related]
11. Hormone-Replacement Therapy for Melanocyte-Stimulating Hormone Deficiency. Reitman ML N Engl J Med; 2016 Jul; 375(3):278-9. PubMed ID: 27468065 [No Abstract] [Full Text] [Related]
12. Relationship of α-MSH and AgRP axons to the perikarya of melanocortin-4 receptor neurons. Lima LB; Pedroso JAB; Metzger M; Gautron L; Donato J Brain Res; 2019 Aug; 1717():136-146. PubMed ID: 31009611 [TBL] [Abstract][Full Text] [Related]
13. Cardiac Phenotype and Tissue Sodium Content in Adolescents With Defects in the Melanocortin System. Puder L; Roth S; Krabusch P; Wiegand S; Opitz R; Bald M; Flück C; Schulz E; Voss E; Markó L; Linz P; Berger F; Müller DN; Kuehne T; Litt MJ; Cone RD; Kühnen P; Kelm M J Clin Endocrinol Metab; 2021 Aug; 106(9):2606-2616. PubMed ID: 34036349 [TBL] [Abstract][Full Text] [Related]
14. Desacetyl-α-melanocyte stimulating hormone and α-melanocyte stimulating hormone are required to regulate energy balance. Mountjoy KG; Caron A; Hubbard K; Shome A; Grey AC; Sun B; Bould S; Middleditch M; Pontré B; McGregor A; Harris PWR; Kowalczyk R; Brimble MA; Botha R; Tan KML; Piper SJ; Buchanan C; Lee S; Coll AP; Elmquist JK Mol Metab; 2018 Mar; 9():207-216. PubMed ID: 29226825 [TBL] [Abstract][Full Text] [Related]
15. Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin. Yaswen L; Diehl N; Brennan MB; Hochgeschwender U Nat Med; 1999 Sep; 5(9):1066-70. PubMed ID: 10470087 [TBL] [Abstract][Full Text] [Related]
16. Two Cases With an Early Presented Proopiomelanocortin Deficiency-A Long-Term Follow-Up and Systematic Literature Review. Gregoric N; Groselj U; Bratina N; Debeljak M; Zerjav Tansek M; Suput Omladic J; Kovac J; Battelino T; Kotnik P; Avbelj Stefanija M Front Endocrinol (Lausanne); 2021; 12():689387. PubMed ID: 34177811 [TBL] [Abstract][Full Text] [Related]
17. The central melanocortin system and the integration of short- and long-term regulators of energy homeostasis. Ellacott KL; Cone RD Recent Prog Horm Res; 2004; 59():395-408. PubMed ID: 14749511 [TBL] [Abstract][Full Text] [Related]
18. In vivo evidence for inverse agonism of Agouti-related peptide in the central nervous system of proopiomelanocortin-deficient mice. Tolle V; Low MJ Diabetes; 2008 Jan; 57(1):86-94. PubMed ID: 17909095 [TBL] [Abstract][Full Text] [Related]
19. A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans. Sun EW; Iepsen EW; Pezos N; Lumsden AL; Martin AM; Schober G; Isaacs NJ; Rayner CK; Nguyen NQ; de Fontgalland D; Rabbitt P; Hollington P; Wattchow DA; Hansen T; Holm JC; Liou AP; Jackson VM; Torekov SS; Young RL; Keating DJ Gastroenterology; 2021 Aug; 161(2):536-547.e2. PubMed ID: 33848536 [TBL] [Abstract][Full Text] [Related]
20. 60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH. Anderson EJ; Çakir I; Carrington SJ; Cone RD; Ghamari-Langroudi M; Gillyard T; Gimenez LE; Litt MJ J Mol Endocrinol; 2016 May; 56(4):T157-74. PubMed ID: 26939593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]